Maxrica M75 Tablet SR is a sustained-release formulation combining Methylcobalamin 1500 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by modulating calcium channel activity in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety symptoms. This combination is particularly beneficial in conditions such as diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathies where nerve damage and pain coexist. The sustained-release formulation ensures a gradual and consistent release of active ingredients, improving patient compliance and maintaining stable plasma drug levels over an extended period. Maxrica M75 is typically prescribed under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances. Patients with renal impairment or hypersensitivity to either component should use this medication cautiously. Overall, Maxrica M75 Tablet SR offers a synergistic approach to neuropathic pain management by combining neurotrophic support with effective analgesia.